AOAAM Education
Saturday, August 3, 2020
Introduction and Welcome
A Genetic and Neurobiologic Understanding of Addiction 7:30am - 8:00am EST
8:00am - 8:50am EST
Overview
Welcome to the AOAAM Addiction Medicine Board Certification Review Course! This session is a review of the genetic underpinnings of the individual susceptibility and development of addiction. This will be tied into the potential environmental and epigenetic influences on genetics. Flowing from there will be a review of the current understanding of the neurobiology of addiction, from first reward to the development of the disease.
Agenda and Speakers
Introduction and Welcome
7:30am - 8:00am
Julie Kmiec, DO
A Genetic and Neurobiologic Understanding of Addiction
8:00am - 8:50am
Stephen Wyatt, DO
A Comprehensive Review of Opioid Use Disorder 9:00am - 10:50 am EST
Overview
This session reviews the epidemiology of opioid use disorder and opioid overdose deaths, diagnosis of opioid use disorder, opioid intoxication, and opioid withdrawal, in addition to treatments for opioid withdrawal, and medications for opioid use disorder.
Agenda and Speakers
A Comprehensive Review of Opioid Use Disorder: Part One
9:00am - 9:50am
Julie Kmiec, DO
Break
9:50am - 10:00am
A Comprehensive Review of Opioid Use Disorder: Part Two
10:00am - 10:50am
Julie Kmiec, DO
Tobacco Use Disorders 11:00am - 11:50am EST
Overview
This presentation will review the diagnoses, epidemiology, and management of Tobacco Use Disorders to include smokeless tobacco, E-Cigarettes, co-occurring disorders, and medication assisted options.
Agenda and Speakers
Tobacco Use Disorders
11:00am - 11:50am
R. Gregory Lande, DO
Lunch time Q&A 12:00pm - 12:30pm EST
Overview
Question and Answer Session with today's speakers.
Agenda and Speakers
Lunch time Q&A
12:00pm - 12:30pm
All Speakers
Cannabis / Medical Marijuana 12:30pm - 1:20pm EST
Overview
Cannabis issues are no longer black and white. As America continues to produce cannabis friendly states we must use evidence-based data not industry-based propaganda to position cannabis risk alongside alcohol and prescription psychotropics. Cannabis is more than decriminalization. 50 shades of green are difficult to navigate and we teach clear translation of some of the ambiguous laws to properly place cannabis in a risk reduction model. 8 unarguable highlights of cannabis and risk assignment come down to thoughtfully answer questions that nobody else will clarify.
Agenda and Speakers
Cannabis / Medical Marijuana
12:30pm - 1:20pm
William Morrone, DO
A Comprehensive Review of Alcohol Use Disorders 1:30pm - 3:20pm EST
Overview
During this course there will be a review of the epidemiology of alcohol use disorders. There will information on the individual susceptibility to the disease and how understanding this can lead to individualize prevention. The screening for and brief intervention of alcohol use, will be reviewed along with the biologic markers of the disease. Treatment of alcohol use disorders will be reviewed from current withdrawal recommendations to post abstinent chronic care.
Agenda and Speakers
A Comprehensive Review of Alcohol Use Disorders: Part One
1:30pm - 2:20pm
Stephen Wyatt, DO
Break
2:20pm - 2:30pm
A Comprehensive Review of Alcohol Use Disorders: Part Two
2:30pm - 3:20pm
Stephen Wyatt, DO
Stimulant Use Disorder: Clinical & Practice Implications 3:30 - 4:20pm EST
Overview
Stimulant use disorder includes amphetamines, methamphetamines, cocaine, and other stimulants. This presentation covers the neurobiology of stimulant use disorder, definition of stimulant use disorder and prevalence, its clinical manifestations including intoxication and withdrawal, misuse and diversion of prescription stimulants, and treatment approaches for individuals with stimulant use disorder.
Agenda and Speakers
Stimulant Use Disorder: Clinical & Practice Implications
3:30pm - 4:20pm
Antoine Douaihy, MD
Q&A Session 4:30pm - 5:00 pm EST
Overview
Question and Answer Session with today's speakers.
Agenda and Speakers
Q&A Session
4:30pm - 5:00pm
All Speakers